Tonix pharmaceuticals holding corp. (TNXP)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
COSTS AND EXPENSES:
Research and development

18,972

18,192

17,559

15,771

16,284

17,558

16,135

16,779

15,518

13,342

14,588

16,146

20,856

28,533

33,143

37,991

39,346

35,504

31,789

26,692

21,896

18,617

14,170

10,590

7,459

4,650

4,192

3,213

2,927

2,584

2,237

2,071

1,476

1,158

0

0

0

-

-

General and administrative

10,856

10,636

10,185

9,623

9,347

8,764

8,080

7,730

7,670

7,949

8,670

8,886

9,190

10,436

11,718

12,541

13,134

12,658

11,975

11,226

10,287

9,039

8,191

7,429

6,597

6,238

5,019

4,641

4,575

4,078

3,885

3,332

2,548

2,220

1,251

730

0

0

0

Total costs and expenses

29,828

28,828

27,744

25,394

25,631

26,322

24,215

24,509

23,188

21,291

23,258

25,032

30,046

38,969

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

32,183

27,656

22,361

18,019

14,056

10,888

9,211

7,854

7,502

6,662

6,123

5,403

4,025

3,378

0

0

0

-

-

Operating Loss

-29,828

-28,828

-27,744

-25,394

-25,631

-26,322

-24,215

-24,509

-23,188

-21,291

-23,258

-25,032

-30,046

-38,969

-44,861

-50,532

-52,480

-48,162

-43,764

-37,918

-32,183

-27,656

-22,361

-18,019

-14,056

-10,888

-9,211

-7,854

-7,502

-6,662

-6,123

-5,403

-4,025

-3,378

0

0

0

-

-

Interest income, net

170

210

245

254

244

233

221

208

194

168

146

128

116

127

141

140

131

108

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

2

3

0

0

-

0

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,224

-1,177

47

0

0

-

0

-

0

-

-

Interest income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40

27

14

9

4

-710

-711

-711

-1,613

-900

-901

0

-

0

0

-

-

-

Interest and other financing costs, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Mineral Property Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Professional Fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net loss

-29,658

-28,618

-27,499

-25,140

-25,387

-26,089

-23,994

-24,301

-22,994

-21,123

-23,112

-24,904

-29,930

-38,842

-44,720

-50,392

-52,349

-48,054

-43,683

-37,852

-32,133

-27,616

-22,334

-18,005

-14,047

-10,884

-11,147

-9,789

-9,436

-9,450

-7,065

-6,347

-4,971

-3,470

-1,887

-875

0

0

0

Warrant deemed dividend

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock deemed dividend

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss available to common stockholders

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per common share, basic and diluted (in dollars per share)

-0.37

0.07

-5.69

-0.95

-12.76

-188.83

-54.99

-7.23

-8.80

-29.00

-0.77

-0.65

-1.27

-0.13

-2.90

-4.97

-7.41

-26.46

-0.72

-0.73

-0.71

-0.86

-0.71

-0.61

-0.59

-0.62

-0.87

-0.95

-0.93

-3.25

-0.05

-1.01

-1.27

-3.14

-0.05

-0.02

-0.03

0.00

0.00

Weighted average common shares outstanding, basic and diluted (in shares)

24,028

-1,598

1,377

6,167

488

-1,277

99

842

787

-16,155

7,508

7,327

3,985

3,611

2,613

1,973

1,886

-41,541

18,423

16,137

13,696

10,804

10,496

9,923

8,718

5,042

3,537

2,186

2,159

-30,801

34,278

1,713

1,582

-

20,667

19,716

-

-

-

Weighted average common shares outstanding, basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,657

-

-

Weighted average number of common shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,500

5,500